EUVIMEDEUVIMED entdecken
Open Access

Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub

Chien-Chang Kao, Jing-Wen Shih, Huong Thi Luu Kim Huynh, Ching-Hsin Chang, Bashir Lawal, Sitthichai Iamsaard, Nur Azizah, Ritmaleni Ritmaleni, Justin Kung-Yi Lin, Po-Yang Huang, Alexander T H Wu, Ming-Che Liu

International Journal of Medical Sciences · 2025

DOI: 10.7150/ijms.107228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Chien-Chang Kao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Alkaloids. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsAlkaloidsHumansAnimalsNeoplastic Stem CellsMiceYAP-Signaling ProteinsSignal TransductionCancer-Associated FibroblastsCell Line, TumorXenograft Model Antitumor AssaysTumor MicroenvironmentDrug Resistance, NeoplasmTranscription FactorsDown-RegulationGene Expression Regulation, NeoplasticAdaptor Proteins, Signal TransducingMolecular Docking Simulation

Stichwörter der Autor:innen

TGFβ3/GLI2/YAP1 signalingbladder cancercancer stem cellscancer-associated fibroblastscisplatin resistancetrigonelline

Substanzen

YAP-Signaling ProteinsYAP1 protein, humanAlkaloidsTranscription FactorsAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan.
  • Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
  • TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • International PhD Program for Translational Science, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
  • Institute of Microbiology and Immunology, National Yang-Ming Chiao Tung University, Hsinchu 30010, Taiwan.

Zitieren

APA

Kao, C. C., Shih, J. W., Huynh, H. T. L. K., Chang, C. H., Lawal, B., Iamsaard, S., Azizah, N., Ritmaleni, R., Lin, J. K., Huang, P. Y., Wu, A. T. H., & Liu, M. C. (2025). Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.107228

Vancouver

Kao CC, Shih JW, Huynh HTLK, Chang CH, Lawal B, Iamsaard S, et al. Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.107228

BibTeX
@article{Kao2025,
  author = {Kao, Chien-Chang and Shih, Jing-Wen and Huynh, Huong Thi Luu Kim and Chang, Ching-Hsin and Lawal, Bashir and Iamsaard, Sitthichai and Azizah, Nur and Ritmaleni, Ritmaleni and Lin, Justin Kung-Yi and Huang, Po-Yang and Wu, Alexander T H and Liu, Ming-Che},
  title = {Nutraceutical Evaluation of Trigonelline's Therapeutic Potential by Targeting Bladder Cancer Stem Cells and Cancer-Associated Fibroblasts via Downregulation of TGFβ3/GLI2/YAP1 Signaling Hub},
  journal = {International Journal of Medical Sciences},
  year = {2025},
  doi = {10.7150/ijms.107228}
}
Kostenlos starten →